- Home
- GCMG vs NKTR Comparison
GCMG vs NKTR Comparison
Compare GCMG & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCMG
- NKTR
- Stock Information
- Founded
- GCMG 1971
- NKTR 1990
- Country
- GCMG United States
- NKTR United States
- Employees
- GCMG N/A
- NKTR N/A
- Industry
- GCMG Finance/Investors Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- GCMG Finance
- NKTR Health Care
- Exchange
- GCMG Nasdaq
- NKTR Nasdaq
- Market Cap
- GCMG 631.4M
- NKTR 558.0M
- IPO Year
- GCMG N/A
- NKTR 1994
- Fundamental
- Price
- GCMG $12.89
- NKTR $47.42
- Analyst Decision
- GCMG Buy
- NKTR Strong Buy
- Analyst Count
- GCMG 4
- NKTR 6
- Target Price
- GCMG $15.13
- NKTR $81.67
- AVG Volume (30 Days)
- GCMG 443.2K
- NKTR 1.1M
- Earning Date
- GCMG 11-07-2025
- NKTR 11-06-2025
- Dividend Yield
- GCMG 3.44%
- NKTR N/A
- EPS Growth
- GCMG N/A
- NKTR N/A
- EPS
- GCMG 0.19
- NKTR N/A
- Revenue
- GCMG $533,097,999.00
- NKTR $74,934,000.00
- Revenue This Year
- GCMG $4.88
- NKTR N/A
- Revenue Next Year
- GCMG $11.78
- NKTR N/A
- P/E Ratio
- GCMG $68.86
- NKTR N/A
- Revenue Growth
- GCMG 15.56
- NKTR N/A
- 52 Week Low
- GCMG $10.04
- NKTR $6.48
- 52 Week High
- GCMG $14.48
- NKTR $50.00
- Technical
- Relative Strength Index (RSI)
- GCMG 58.20
- NKTR 83.31
- Support Level
- GCMG $12.63
- NKTR $42.12
- Resistance Level
- GCMG $12.98
- NKTR $50.53
- Average True Range (ATR)
- GCMG 0.18
- NKTR 3.11
- MACD
- GCMG -0.04
- NKTR 1.79
- Stochastic Oscillator
- GCMG 63.93
- NKTR 87.08
About GCMG GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.